Download PDF
Facial Plast Surg 2024; 40(04): 525-537
DOI: 10.1055/s-0044-1786824
Original Research

Selective Neurectomy for Postfacial Paralysis Synkinesis: A Systematic Review

Amirpouyan Namavarian   *
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Emily YiQin Cheng   *
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Justin Shapiro 
2   Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada
,
Hedyeh Ziai
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
,
Benjamin Talei
3   Beverly Hills Center for Facial Plastic Surgery, Beverly Hills, California
,
Akshat Pai
4   Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Ontario, Canada
,
Danny Enepekides
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
5   Department of Otolaryngology-Head and Neck Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
,
Andres M. Gantous 
1   Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Facial synkinesis is characterized by unintentional contractions of facial musculature secondary to aberrant facial nerve healing. The associated impairment in facial functioning results in a significant decrease in patients' quality of life. The mainstay treatment for postfacial paralysis synkinesis (PFPS) is chemodenervation and physiotherapy, which requires long-term maintenance neurotoxin injections. This can lead to treatment resistance. Selective neurectomy of the distal branches of the facial nerve has been suggested as an effective surgical treatment of PFPS. This study aims to provide a comprehensive systematic review evaluating the efficacy of selective neurectomy for patients presenting with PFPS. Ovid MEDLINE, Ovid Embase, PubMed, Web of Science, and CINAHL were searched from inception until July 2022. Studies that investigated postoperative outcomes of pediatric and/or adult patients who underwent selective neurectomy as a treatment for PFPS were included. The database search identified 1,967 studies, and 11 were ultimately included based on inclusion and exclusion criteria. These 11 studies represented 363 patients. Studies reported on outcomes following selective neurectomy with or without adjuvant therapies for patients with PFPS. The main outcome categories identified were clinician-reported outcomes and patient-reported outcomes. The studies that used clinician-reported outcomes found an improvement in both synkinesis and facial nerve paralysis (FNP) outcomes following selective neurectomy according to their respective grading systems. Three studies looked at patient-reported outcomes and found increased patient-reported quality of life and satisfaction following selective neurectomy. The most reported complications were upper lip contracture, uneven cheek surface, lagophthalmos, and temporary oral incompetence. Selective neurectomy has demonstrated stable or improved synkinesis, FNP, and quality of life outcomes in patients with PFPS. This approach should be considered for patients with PFPS, particularly for patients with refractory symptoms or those who are unable to undergo continued medical management.

Keywords

synkinesis - selective neurectomy - facial nerve paralysis

* These authors have contributed equally to this article and are considered co-first authors.




Publication History

Article published online:
28 May 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Terzis JK, Karypidis D. Therapeutic strategies in post-facial paralysis synkinesis in adult patients. Plast Reconstr Surg 2012; 129 (06) 925e-939e
    CrossrefPubMedSearch in Google Scholar
  • 2 van Veen MM, Dusseldorp JR, Hadlock TA. Long-term outcome of selective neurectomy for refractory periocular synkinesis. Laryngoscope 2018; 128 (10) 2291-2295
    CrossrefPubMedSearch in Google Scholar
  • 3 Chuang DC, Chang TN, Lu JC. Postparalysis facial synkinesis: clinical classification and surgical strategies. Plast Reconstr Surg Glob Open 2015; 3 (03) e320
    CrossrefPubMedSearch in Google Scholar
  • 4 Crumley RL. Mechanisms of synkinesis. Laryngoscope 1979; 89 (11) 1847-1854
    CrossrefPubMedSearch in Google Scholar
  • 5 Couch SM, Chundury RV, Holds JB. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox). Ophthal Plast Reconstr Surg 2014; 30 (03) 246-250
    CrossrefPubMedSearch in Google Scholar
  • 6 Vincent AG, Bevans SE, Robitschek JM, Wind GG, Hohman MH. Masseteric-to-facial nerve transfer and selective neurectomy for rehabilitation of the synkinetic smile. JAMA Facial Plast Surg 2019; 21 (06) 504-510
    CrossrefPubMedSearch in Google Scholar
  • 7 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 (07) e1000097
    CrossrefPubMedSearch in Google Scholar
  • 8 Spector GJ. Selective facial neurectomy for spastic disorders of the facial nerve. Otolaryngol Head Neck Surg 1985; 93 (02) 168-173
    CrossrefPubMedSearch in Google Scholar
  • 9 Wells GA, Shea B, O'Connell D. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed April 23, 2023 at: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
    PubMed
  • 10 Ma Y, Zhang X, Fan D, Xia Q, Wang M, Pan F. Common trace metals in rheumatoid arthritis: a systematic review and meta-analysis. J Trace Elem Med Biol 2019; 56: 81-89
    CrossrefPubMedSearch in Google Scholar
  • 11 Chuang DCC. Thirty-five year experience of an aggressive surgical intervention for treating post-paralytic facial synkinesis: an outcome study. Plast Aesthet Res 2021; 8: 5
    PubMedSearch in Google Scholar
  • 12 Miller MQ, Hadlock TA. Deep dive into denervation: institutional experience with selective denervation in nonflaccid facial palsy. Facial Plast Surg Aesthet Med 2021; 23 (04) 241-247
    CrossrefPubMedSearch in Google Scholar
  • 13 Azizzadeh B, Irvine LE, Diels J. et al. Modified selective neurectomy for the treatment of post-facial paralysis synkinesis. Plast Reconstr Surg 2019; 143 (05) 1483-1496
    CrossrefPubMedSearch in Google Scholar
  • 14 Shtraks JP, Mirocha J, Azizzadeh B. Quality of life outcomes after modified selective neurectomy for postfacial paralysis synkinesis. Facial Plast Surg Aesthet Med 2021; 23 (06) 443-448
    CrossrefPubMedSearch in Google Scholar
  • 15 Yoshioka N. Selective orbicularis neuromyectomy for postparetic periocular synkinesis. J Plast Reconstr Aesthet Surg 2015; 68 (11) 1510-1515
    CrossrefPubMedSearch in Google Scholar
  • 16 Nakamura K, Murakami S, Kozawa T, Yanagihara N. Surgical treatment of synkinesis. Eur Arch Otorhinolaryngol 1994; S380-S382
    PubMedSearch in Google Scholar
  • 17 Hohman MH, Lee LN, Hadlock TA. Two-step highly selective neurectomy for refractory periocular synkinesis. Laryngoscope 2013; 123 (06) 1385-1388
    CrossrefPubMedSearch in Google Scholar
  • 18 Hjelm N, Crippen M, Azizzadeh B. Long-term changes in the treatment pattern of botulinum toxin A injections for postfacial paralysis synkinesis following modified selective neurectomy. Facial Plast Surg Aesthet Med 2021; 23 (03) 234-235
    CrossrefPubMedSearch in Google Scholar
  • 19 Cooper L, Lui M, Nduka C. Botulinum toxin treatment for facial palsy: a systematic review. J Plast Reconstr Aesthet Surg 2017; 70 (06) 833-841
    CrossrefPubMedSearch in Google Scholar
  • 20 Husseman J, Mehta RP. Management of synkinesis. Facial Plast Surg 2008; 24 (02) 242-249
    Thieme ConnectPubMedSearch in Google Scholar
  • 21 Banks CA, Bhama PK, Park J, Hadlock CR, Hadlock TA. Clinician-graded electronic facial paralysis assessment: the eFACE. Plast Reconstr Surg 2015; 136 (02) 223e-230e
    CrossrefPubMedSearch in Google Scholar
  • 22 Ross BG, Fradet G, Nedzelski JM. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg 1996; 114 (03) 380-386
    CrossrefPubMedSearch in Google Scholar
  • 23 Gaudin RA, Robinson M, Banks CA, Baiungo J, Jowett N, Hadlock TA. Emerging vs time-tested methods of facial grading among patients with facial paralysis. JAMA Facial Plast Surg 2016; 18 (04) 251-257
    CrossrefPubMedSearch in Google Scholar
  • 24 House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985; 93 (02) 146-147
    CrossrefPubMedSearch in Google Scholar
  • 25 Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas 2018; 9: 353-367
    CrossrefPubMedSearch in Google Scholar
  • 26 Mehta RP, Hadlock TA. Botulinum toxin and quality of life in patients with facial paralysis. Arch Facial Plast Surg 2008; 10 (02) 84-87
    CrossrefPubMedSearch in Google Scholar
  • 27 Finsterer J. Management of peripheral facial nerve palsy. Eur Arch Otorhinolaryngol 2008; 265 (07) 743-752
    CrossrefPubMedSearch in Google Scholar